Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeOur CompanyOur societal impact Global Health Equity Spotlighting the global quest for an HIV vaccine
      hqdefault.jpg

      Spotlighting the global quest for an HIV vaccine

      Share Article
      share to

      In observance of the 20th HIV Vaccine Awareness Day (May 18), Dr. Hanneke Schuitemaker, Head of Viral Vaccine Discovery and Translational Medicine at Janssen Vaccines, and Matthew Hodson, Executive Director of the HIV/AIDS information provider NAM, sat down with The Business Debate. During the interview, they discussed the challenges involved in developing an HIV vaccine and the importance of global partnerships if we are to achieve an HIV-free world. For more information about Johnson & Johnson’s work to fight HIV/AIDS, go to www.jnj.com/hiv.

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.